ReviewWorld journal of microbiology & biotechnology2026
Multi-level metabolic engineering for squalene production: from pathway optimization to systematic regulation.
Review in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Squalene is a high-value unsaturated triterpene extensively used in pharmaceuticals, cosmetics, and health products. Traditional extraction methods of squalene from shark oil are environmentally unfriendly, making it imperative to explore better production approaches. Microbial engineering for squalene production has drawn much attention due to its environmentally friendly nature, sustainability, and high efficiency. However, the capacity of squalene biosynthesis is still limited by many challenges, including insufficient precursor supply, metabolic flux competition, product toxicity, and extracellular transport. To address these issues, this review systematically summarizes various metabolic engineering strategies to enhance squalene production at three hierarchies, including pathway, organelle, and cell. At the pathway level, we discuss several common metabolic engineering strategies to improve the biosynthetic pathways of squalene, including enhancing precursor supply, regulating cofactor levels, and inhibiting competing metabolic pathways. At the organelle level, we underscore the application of organelle engineering in peroxisomes, mitochondria, and endoplasmic reticulum to achieve compartmentalized storage of squalene, alleviate product cytotoxicity, reduce distribution of precursor metabolic flux, and improve catalytic efficiency. At the cell level, cellular production capacity can be comprehensively improved to achieve high-level production of squalene by regulating lipid metabolism, promoting squalene secretion, modulating transcription factors, and combining mutagenesis and evolution. These metabolic engineering strategies not only offer comprehensive guidance for the efficient squalene biosynthesis but also establish a theoretical and technical foundation for the microbial production of other high-value terpenoids.
Indexed as
Identifiers
42828706What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.